IL17A and myocarditis: IL-17 has recently been shown to play a pathogenic role in post-myocarditis remodelling and DCM development in mice, suggesting that excessive Th17 lymphocytes activity may be one of the factors determining disease progression (Baldeviano et al, 2010; Nindl et al, 2012).